. HIV-1 and TB are among the ten leading causes of death worldwide. The interaction between these two pathogens substantially contributes to this high incidence of mortality. HIV-1 co-infection is the single greatest risk factor for developing active TB, and M. tuberculosis co-infection leads to increased viral replication that may contribute to HIV-1 disease progression. Estimates for the incidence of HIV-1 and M. tuberculosis infection in 2015 highlight the scale of these epidemics 3, 4 
. The geographical convergence of the HIV-1-TB 'syndemics' in Africa and in Eastern Europe, as well as the demographic convergence in particular at-risk groups, such as prisoners 5 and miners in southern Africa 6 , further exacerbate the burden of co-infection morbidity and mortality. The impact of TB is also increasing with the emergence of multidrug-resistant M. tuberculosis (BOX 1) , for which HIV-1 is an independent risk factor 7 . Moreover, the rates of undiagnosed TB in individuals with HIV-1, as revealed by post-mortem studies 8 , suggest that the disease burden associated with co-infection has been underestimated.
An increased risk of TB throughout the course of HIV-1 disease has been established through epi demiological studies 9, 10 (FIG. 1a) . HIV-1 co-infection also influences the clinical phenotype of TB. Individuals who are infected with HIV-1 and have CD4 + T cell counts in the normal range present with classic symptoms of pulmonary TB, but disease that is restricted to the lung apices is less frequent, whereas pleural effusions and lymph node disease are more likely 11 . In advanced AIDS, M. tuberculosis frequently causes disseminated extra-pulmonary disease and mycobacteraemia 12, 13 . TB may also exacerbate HIV-1 disease and AIDS progression (FIG. 1b) . Active TB is associated with higher HIV-1 viral loads in the blood 14 and cerebrospinal fluid 15 and an increased genetic heterogeneity of the viral quasispecies 16 . These effects are likely to be driven by increases in HIV-1 replication at the site of co-infection 17, 18 . In addition, M. tuberculosis coinfection may contribute to higher levels of systemic immune activation associated with HIV-1 disease progression 19, 20 , even in the context of latent TB infection (LTBI) 21 . The importance of these phenotypes in driving HIV-1 disease progression is unknown, but based on our understanding of how high viral loads 22 and immune activation 23 can drive immunosuppression, co-infection with M. tuberculosis may accelerate AIDS progression. Accordingly, TB has been associated with an increased incidence of additional opportunistic infections 24 and may be an independent risk factor for progression to AIDS 25 . This hypothesis is supported by the observation that an episode of successfully treated 
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Development of a detectable plasma viral load in an individual with HIV-1 following a period of virological suppression, typically associated with an interruption in antiretroviral therapy or the development of drug resistance.
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Tissue-resident cells that initiate a host immune response.
TB is associated with a fourfold increase in all-cause mortality in populations infected with HIV-1 (REF. 26 ).
Understanding the mechanisms that underpin HIV-1 and M. tuberculosis co-infection is paramount to identifying the best approaches to overcome the global burden of disease caused by these pathogens. In this Review, we describe the specific host-pathogen interactions that have emerged as common features of both organisms, in particular their ability to infect macrophages and induce type 1 interferon responses, as well as the role of chronic or dysregulated inflammation in the pathogenesis of disease. We then describe our current understanding of the mechanisms by which each microorganism influences the pathogenesis of the co-infecting pathogen and consider the future challenges for research in this field. (FIG. 2) . Given that macrophages are the primary intracellular niche for M. tuberculosis, their permissiveness to HIV-1 raises the possibility that the two pathogens can co-infect individual cells. HIV-1 infection of monocyte-derived macrophages in vitro is well described, despite the fact that macrophages express SAMHD1, an endo nuclease that is active in non-dividing cells. SAMHD1 has dNTPase activity and therefore depletes the cell of nucleo tides that are required for DNA synthesis, thereby restricting HIV-1 reverse transcription 28 . The simian immunodeficiency virus (SIV) accessory protein Vpx (which is absent in HIV-1) degrades SAMHD1 and makes human myeloid cells more permissive to retro viral infection. Interestingly, Vpx-deficient SIV still infects myeloid cells in non-human primates 29 , suggesting that Vpx is not necessary for infection of myeloid cells in vivo. Nonetheless, the observation that HIV-1 has not evolved to counteract SAMHD1 restriction had led to the hypothesis that HIV-1 infection of macrophages does not occur in vivo. However, sub populations of human macrophages enter a G1-like state in which SAMHD1 activity is downregulated, making the cells substantially more permissive to HIV-1 (REF. 30 ). These data provide a mechanism by which a retrovirus that cannot counteract SAMHD1 restriction is able to infect non-dividing myeloid cells. A subset of human alveolar macrophages that are infected with HIV-1 in vivo have been identified by RNA fluorescence in situ hybridization, suggesting that the virus in these cells is transcriptionally active 31 . Furthermore, sustained HIV-1 replication in the absence of T cells has been demonstrated in non-human primates and in humanized mouse models 32, 33 . Taken together, this substantial body of data supports the conclusion that macrophages harbour replicative HIV-1 infection in vivo.
HIV-1 infection
Long-lived memory CD4 + T cells are thought to be the dominant cell type in which HIV-1 can establish latency and evade clearance by antiretroviral therapy (ART). Proviral DNA can also be detected in alveolar macrophages in patients on ART 34 . Moreover, viral rebound following ART treatment interruption has been described in humanized myeloid-only mice, indicating that macrophages may also act as a long-term viral reservoir 35 . Importantly, the viral reservoir during ART is not completely latent but exhibits low levels of to evade innate immune detection in macrophages may have an important role in establishing persistent HIV-1 infection.
HIV-1 infection as a chronic inflammatory disease.
HIV-1 infection is increasingly considered a chronic inflammatory disease that leads to immunodeficiency. Inflammatory markers are elevated throughout the asymptomatic phase of infection 52 and correlate with the rate of progression to AIDS 23 . The same phenotype is not evident in non-pathogenic SIV infection of non-human primates or in children infected with HIV-1 who do not progress to immunodeficiency 53 . Several mechanisms are thought to lead to the chronic immune activation that is associated with HIV-1 infection 52 . Chief among these is the translocation of microbial products from the gastrointestinal lumen into the bloodstream following massive T cell depletion in gastrointestinal-associated lymphoid tissue (GALT) during primary HIV-1 infection. This depletion is thought to be caused by lytic infection of GALT T helper17 cells (T H 17 cells) 54 , which are particularly permissive to retroviral infection 55 . Non-productive HIV-1 infection of resting T cells by cell-cell spread in lymphoid tissue may also contribute to T cell depletion and immune activation. In this model, incomplete DNA products of reverse transcription are recognized by the cytosolic DNA sensor IFI16, leading to the activation of the inflammasome and resulting in cell death by pyroptosis and the release of pro-inflammatory interleukin-1β (IL-1β) 56, 57 , thereby linking CD4 + T cell depletion and chronic inflammation 58, 59 . In contrast to this inflammatory mechanism of T cell death, HIV-1 proviral DNA integration may activate DNA damage pathways that can cause T cell apoptosis 60 . Chronic immune activation may also lead to premature immune senescence or compensatory The strong link between HIV-1 infection and chronic inflammation raises the question of whether the virus gains an advantage by driving this phenotype, an advantage that co-infection with M. tuberculosis may be expected to compound, as it also induces chronic inflammation. Inflammatory signalling may benefit HIV-1 by directly stimulating viral replication (discussed below). In addition, the recruitment of leukocytes could potentially provide HIV-1 with a source of target cells to infect. This may be particularly important as HIV-1 infects new cells most efficiently by direct cell-cell transmission via a 'virological synapse' actively orchestrated by the virus 64 . Cell-cell transmission also shields the virus from neutralizing antibodies 65 , leads to more rapid viral gene expression 66 and enables the virus to overcome cell tropism barriers, such as infection of macrophages by non-macrophage tropic viruses 67 .
M. tuberculosis infection
Infection of macrophages. M. tuberculosis is a facultative intracellular pathogen of macrophages. Once inside, M. tuberculosis quickly adapts to the environment within the phagosome through transcriptional reprogramming in order to upregulate iron scavenging mechanisms, to switch to anaerobic respiratory pathways and to use cholesterol as a carbon source and aspartate as a nitrogen source 68 . Within macrophages, M. tuberculosis-containing phagosomes fail to undergo the normal process of maturation and acidification that is associated with phagolysosomal fusion and by which phagosomal cargo is usually degraded. Multiple M. tuberculosis virulence factors are thought to contribute to this phenotype 69 . Nature Reviews | Microbiology 
Pyroptosis
A specific cell death pathway triggered by activation of caspase 1.
Immune senescence
The observable decline in immune function associated with ageing.
Immunoregulation
Mechanisms by which the immune system self-regulates via negative feedback loops, for example, the production of immunosuppressive cytokines.
Macrophage cell death is a key feature of granulomatous pathology in TB. Central to this process is the bacterial ESX-1 secretion system and the secreted effector molecule ESAT6. These are encoded by the RD1 locus that is deleted in the live attenuated Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. ESX-1 is required for M. tuberculosis to escape from phagosomes into the host cell cytoplasm and for triggering cell death pathways 70 . ESAT6 can also trigger macrophage cell death through apoptosis 71 . In addition, ESAT6 has been reported to activate the inflammasome 72 , suggesting that M. tuberculosis may cause cell death through inflammasome-caspase 1-mediated pyroptosis. The triggering of cell death promotes bacterial dissemination through efferocytosis 73 and by releasing bacteria into the extracellular space for onward transmission to new hosts.
Induction of innate immune type 1 interferon responses. Mycobacterial lipids, lipoproteins and nucleic acids trigger a range of innate immune responses when they are sensed by host PRRs within macrophages 74, 75 . These responses are thought to be crucial for further immune cell recruitment and for the production of antimicrobial peptides 76 . Innate immune responses to M. tuberculosis include type 1 interferon responses that have conventionally been associated with anti viral responses 77 . The observation that type 1 inter ferons are immunosuppressive in chronic viral infections has led to studies to determine whether type 1 interferons counteract immunoprotective interferon-γ (IFNγ)-dependent or IL-1β-dependent mechanisms of M. tuberculosis clearance 78 . Induction of type 1 interferon responses is principally mediated through the recognition of M. tuberculosis nucleic acids by the cytosolic DNA sensor cGAS 75 . This induction is dependent on ESX-1-mediated M. tuberculosis phagosomal escape, which also drives inflammasome maturation of IL-1β 79 . Interestingly, the levels of effector molecules (ESAT6) that are secreted by the ESX-1 system determine the outcome of host cellular responses polarized towards either type 1 interferons or IL-1β. M. tuberculosis strains that are more virulent have been found to produce more ESAT6 and more type 1 interferons 80 .
Chronic inflammation to promote transmission.
Similar to HIV-1 infection, chronic inflammation is the hallmark of TB pathology. Immunopathogenesis may even be more important in this case because, unlike HIV-1, M. tuberculosis is an obligate pathogen (it must cause disease in order to transmit). Its ability to escape the intracellular niche, cause pulmonary cavitation and induce coughing through chronic inflammation within airways is necessary for its dispersal between individuals. Matrix metalloproteinase 1 (MMP1) has a crucial role in pulmonary cavitation that is associated with M. tuberculosis infection 81 . This protein belongs to a family of host proteinases that degrade the extracellular matrix. MMPs are produced by macrophages, epithelial cells and fibroblasts in response to pro-inflammatory cytokines. In this context, chronic pro-inflammatory T cells may contribute to the pathology in response to persistent M. tuberculosis. The observation that virulent M. tuberculosis strains have highly conserved immunodominant T cell epitopes suggests that M. tuberculosis does not rely on antigenic variation to evade protective immunity 82, 83 . In addition, it raises the possibility that the conservation of these immunodominant responses may be beneficial to the pathogen. Thereby, M. tuberculosis may commandeer T cell responses to promote immunopathology and, consequently, its transmission.
HIV-1 and M. tuberculosis co-infection HIV-1 depletion of M. tuberculosis-reactive T cells.
Despite the hypothesis presented above that T cell responses in TB may contribute to pathogenesis of disease, they have long been thought to have an important role in immunological protection against M. tuberculosis by promoting intracellular bacterial killing or restriction (FIG. 2) . Genetic deficiencies in IL-12 signalling (which is required for T H 1 cell differentiation) or IFNγ signalling (representing the canonical product of T H 1 cell responses) give rise to Mendelian susceptibility to mycobacterial disease 84 . HIV-1 co-infection further highlights the importance of T cell-mediated Nature Reviews | Microbiology 
Granulomatous pathology
Chronic inflammatory foci within tissues, primarily made up of a core of activated macrophages surrounded by CD4 + T cells.
Efferocytosis
The process by which dead or dying cells are cleared by phagocytosis.
Pulmonary cavitation
Formation of large airspaces in the lung parenchyma due to tissue destruction.
Pro-inflammatory cytokines
Extracellular signalling molecules secreted chiefly by immune cells, which induce cell-surface receptors to trigger inflammatory processes.
Immunodominant
The antigenic epitopes most commonly targeted by the adaptive immune response. immunity. A substantially increased risk of TB and its extra-pulmonary dissemination is strongly correlated with CD4 + T cell depletion in individuals infected with HIV-1. T cell depletion is evident in peripheral blood, in the respiratory tract and at the site of tuberculin skin test (TST) challenge [85] [86] [87] . Assuming that CD4 + T cell protection against M. tuberculosis is conferred by the proinflammatory cytokines that they produce, it is notable that the proportions of polyfunctional M. tuberculosisreactive T cells, which produce the pro-inflammatory cytokines IFNγ, tumour necrosis factor (TNF) and IL-2, are also depleted in individuals infected with HIV-1 (REF. 86 ). Hence, HIV-1 depletes T cell populations that are likely to be functionally important for protection against TB. Transcriptional profiling of biopsy samples taken from the site of the TST challenge in humans confirmed that T cell recruitment and IFNγ activity were both substantially reduced in patients co-infected with HIV-1 and TB, with blood CD4 + T cell counts of <200 per mL, indicative of advanced HIV-1 disease 85 .
Tuberculin skin test
HIV-1-infected T cells may also contribute to the increased risk of TB in early HIV-1 disease before substantial depletion of peripheral blood CD4 + T cell counts 87 . HIV-1 DNA was detected more frequently in M. tuberculosis-specific T cells. These T cells produced high levels of IL-2, which made them more permissive to HIV-1 infection. In comparison to the total memory T cell population or memory T cells that specifically recognize human cytomegalovirus, M. tuberculosisspecific T cells were preferentially depleted in early HIV-1 infection. Taken together, these data suggest that the depletion of these cells is a direct result of HIV-1 infection. Transcriptional profiling of the biopsy samples from the TST challenge site in patients co-infected with HIV-1 and TB with blood CD4 + T cell counts >200 per mL also revealed less T cell recruitment at the site of the antigenic challenge than with HIV-1 negative patients with active TB 85 . However, the functional relevance of the reduced T cell recruitment observed in this study is currently unknown, as comparable levels of IFNγ inducible gene expression were found in the groups with and without HIV-1. Hence, IFNγ activity as a surrogate of robust CD4 + T cell responses to mycobacterial antigens was preserved in early HIV-1 disease, despite previous reports of preferential depletion of M. tuberculosisspecific T cells. These data suggest that the increased risk of TB in patients infected with HIV-1 is not solely mediated by T cell depletion.
Of the other T cell populations that may contribute to HIV-1-associated TB, T H 17 and T H 22 cells are the most plausible candidates. A functional role for these T cell populations in immunological protection against TB is primarily based on data obtained from experiments in mice and on their role in the recruitment of phagocytic cells including macrophages [88] [89] [90] . The depletion of these T cell subtypes during primary HIV-1 infection 54, 91 may therefore contribute to differences in the immune response to M. tuberculosis in patients co-infected with HIV-1 compared with patients not infected with HIV-1. Another T cell population that becomes depleted in HIV-1 infection are mucosal associated invariant T (MAIT) cells 92 . 93 . Therefore, their depletion in HIV-1 infection may attenuate a component of host immune responses to M. tuberculosis. MAIT cells are not infected by HIV-1. Their depletion is thought to be caused indirectly by immune activation. Importantly, in comparison to the general population, the risk of active TB remains higher in patients infected with HIV-1 even after becoming established on effective ART 94 . In this context, the failure of ART to restore the T cell repertoire, including MAIT cells 95, 96 , may also be an important factor in the persistently elevated risk of TB.
HIV-1 inhibition of phagocytosis and autophagy in macrophages.
M. tuberculosis has evolved to survive and grow within macrophages. Nonetheless, M. tuberculosis phagocytosis by macrophages is thought to restrict mycobacterial growth. The best evidence for this comes from experiments in the zebrafish Mycobacterium marinum model in which bacillary uptake by macrophages is elegantly visualized. In this model, macrophage depletion, delayed macrophage recruitment and necrotic macrophage cell death are all associated with increased microbial burden 73, 97, 98 . Once the bacteria are phagocytosed, phagolysosomal fusion that would lead to bacterial killing is inhibited by M. tuberculosis. This may be overcome by the autophagy pathway 99, 100 and by inducible production of bactericidal nitric oxide or a range of antimicrobial peptides, all of which are generally upregulated by the action of IFNγ.
HIV-1 infection has been reported to inhibit macrophage phagocytosis dependent on diverse cell surface receptors and mediated by HIV-1 infection of the affected cell 101 . In this study, the HIV-1 accessory protein Nef was found to be both necessary and sufficient to inhibit phagocytosis by directly interacting with adaptor protein AP1 to inhibit the recruitment of recycling endosomes that are required for phagosome biogenesis 101 . It is also possible that these effects are mediated indirectly by the action of circulating virus-free accessory proteins on uninfected macrophages, which can be detected in vivo 102, 103 . Moreover, impaired phagocytosis has also been observed in HIV-1-infected alveolar macrophages ex vivo 31 . Interestingly, HIV-1 Nef also inhibits the autophagy pathway by blocking the maturation of auto phagosomes through a direct interaction with the autophagy regulator beclin 1 (REF. 104 ). This inhibition was found to protect nascent virion assembly from autophagic degradation. Consistent with these effects of HIV-1 infection on phagocytosis and autophagy (FIG. 2) , HIV-1 co-infection in macrophages that are infected with M. tuberculosis has been associated with increased mycobacterial growth 105 . Interestingly, however, vitamin D treatment of co-infected macrophages was reported to restrict both M. tuberculosis and HIV-1 replication by an autophagy-dependent mechanism, suggesting that the inhibition of autophagy by HIV-1 is
Necrotic granulomas
Granulomatous inflammation sites with a core of dead cells.
Bacillary load
The measurable quantity of bacteria within a host organism or sample.
easily overcome by the action of vitamin D 106 . Vitamin D deficiency is undoubtedly prevalent among populations at greatest risk of co-infection 107 . Therefore, if HIV-1 inhibition of autophagy is an important determinant for increased risk of TB, vitamin D supplementation may substantially reduce the incidence of TB disease in patients infected with HIV-1 while at the same time supporting immune control of the virus. However, this hypothesis has yet to be tested in clinical trials.
Macrophage cell death and tissue necrosis in HIV-1 and TB co-infection. HIV-1 does not cause macrophage cell death 51 . A number of reports suggest that HIV-1 proteins reduce M. tuberculosis-associated macrophage apoptosis, potentially by HIV-1 Nef inhibition of TNF responses to M. tuberculosis [108] [109] [110] . Cellular apoptosis has been considered as a mechanism for limiting intracellular M. tuberculosis growth. Therefore, by inhibiting apoptosis, HIV-1 infection may compromise M. tuberculosis restriction. However, live-cell imaging data have recently contradicted this hypothesis by demonstrating that cell death is associated with M. tuberculosis growth rather than restriction 111 . A key observation in patients with HIV-1 and pulmonary TB is the presence of fewer necrotic granulomas and less pulmonary cavitation. Interestingly, in active TB, MMP1 levels are significantly lower in respiratory tract samples from patients infected with HIV-1 with severe CD4 + T cell depletion, compared with patients not infected with HIV-1 (REF. 112 ). These observations have largely supported the hypothesis that T cell responses to M. tuberculosis contribute substantially to cellular necrosis and tissue damage. In agreement with this, cellular necrosis and tissue damage are reduced in patients with AIDS, but improved host cell viability in advanced HIV-1 disease does not achieve better M. tuberculosis control. Consistent with the reduction in pulmonary cavitation, patients co-infected with HIV-1 may transmit less M. tuberculosis 113 . Nonetheless, at the population level, an increased incidence of active TB in patients infected with HIV-1 ultimately promotes the onward transmission of M. tuberculosis.
Immunopathology of M. tuberculosis in patients infected with HIV-1.
The most direct evidence supporting the hypothesis that there is a reduction of M. tuberculosis immunopathology in patients with AIDS is the phenomenon of TB immune reconstitution inflammatory response syndrome (TB-IRIS). TB-IRIS is the development of increased inflammatory pathology in patients following the commencement of ART and may manifest by either a worsening of known TB disease or 'unmasking' of previously asymptomatic M. tuberculosis infection 114 . TB-IRIS occurs in ~15% of patients infected with HIV-1 starting ART 115 and is most commonly found in patients with very low peripheral blood CD4 + T cell counts and evidence of a high M. tuberculosis bacillary load before starting ART. The pathological features of TB-IRIS include systemic responses such as fever and increased acute neutrophilic inflammation at the site of M. tuberculosis infection. Comparisons of peripheral blood transcriptional profiles in cohorts of patients infected with HIV-1 and TB with and without TB-IRIS revealed that in cases of TB-IRIS, there were increases in the expression of type 1 interferon, MYD88 and inflammasome-dependent innate immune responses 116 . These data suggest that TB-IRIS is caused by the recovery of innate immune responses to M. tuberculosis and presumably failure of immuno regulation that would ordinarily control pathogenic innate inflammatory responses. By inference, these data suggest that HIV-1 downregulates innate immune and immuno regulatory responses to M. tuberculosis, as well as classical T H 1 cell responses. With the notable exception of type 1 interferons, the wide repertoire of pro-inflammatory transcriptional innate immune responses at the site of TST challenge was found to be lower in patients with active TB and advanced HIV-1 co-infection than in control patients without HIV-1 (REF. 85 ). By contrast, patients presenting with unmasking TB-IRIS had substantially higher pro-inflammatory transcriptional responses to the TST than patients without HIV-1 with active TB, consistent with exaggerated inflammatory responses. In this study, unmasking TB-IRIS was associated with features that are associated with T H 2 cell responses and increased granulocyte colony-stimulating factor (CSF3; also known as G-CSF) expression that is known to augment neutrophil responses 85 . How HIV-1 might inhibit innate immune responses to M. tuberculosis remains unclear. Both pathogens can infect macrophages, which are widely recognized to generate pro-inflammatory innate immune responses. Attenuated innate immune responses to prototypic stimuli such as lipopolysaccharide (LPS) by alveolar macrophages from individuals infected with HIV-1 has been reported 117, 118 . The HIV-1 accessory proteins Nef, Vpu and Vpr have each been reported to inhibit innate immune intracellular signalling pathways 119 . Consistent with these reports, HIV-1 infection of macrophages attenuated activation of the canonical nuclear factor-κB (NF-κB) pathway in response to LPS 120 . However, genome-wide transcriptional responses to LPS were largely preserved. In the same experimental model of macrophages that were infected with HIV-1, pro-inflammatory innate immune responses to M. tuberculosis co-infection were also preserved 105, 121, 122 . Instead, HIV-1 infection was associated with attenuated immuno regulatory IL-10 expression, leading to exaggerated pro-inflammatory responses at subsequent time points 121 . These data suggest that any HIV-1-associated inhibition of innate immune pro-inflammatory responses to M. tuberculosis does not arise because of co-infection at the cellular level.
Indirect effects on macrophage innate immune responses may also result from HIV-1 modulation of T cells, for example, by alterations in the cytokine milieu that acts on uninfected macrophages. Therefore, an alternative hypothesis may be that pathogenic innate immune responses to M. tuberculosis are amplified by T helper cells. In such a model, the immunopathogenesis of TB-IRIS may be driven by the recirculation of M. tuberculosis-reactive T cells, leading to the recovery of innate immune inflammatory responses and compounded by high bacterial loads that have accumulated in patients with suppressed immune systems, thereby providing a higher dose for stimulation of innate immune responses 114 . In this context, HIV-1 attenuation of IL-10 responses in macrophages may represent foci of deficient immunoregulation that leads to pathological inflammation. In this regard, we found that deficient IL-10 responses persist in infected macrophages in the presence of antiretrovirals in vitro 121 , and others have demonstrated the persistence of dysregulated phagocyte phenotypes after antiretroviral treatment, such as increased TLR2 expression 123 and dysregulation of complement pathways 124 . Hence, TB-IRIS may be caused by a combination of high bacterial burden, T cell recovery and failure of immune regulation in HIV-1-infected macrophages (FIG. 3) . Interestingly, TST challenge experi ments revealed attenuated IL-10 responses in patients infected with HIV-1 with CD4 + T cells >200 per mL (REF. 85 ). Therefore, an increased risk of active TB in early HIV-1 disease may also partly reflect a propensity for immunopathology as a result of inadequate IL-10 regulation.
Effects of TB on HIV-1 replication. An increase in HIV-1 viral loads in the lungs of patients co-infected with pulmonary TB is well established 17, 18, 125 . This is commonly associated with increased viral load in peripheral blood 14 .
Whether the increase in circulating virus arises from replication in the lung alone or is also due to increased systemic virus replication is not known. As most HIV-1 replication occurs in activated T cells, their recruitment to sites of granulomatous inflammation in TB may facilitate rapid virus propagation through the accumulation of tightly packed permissive cells and hence cell-cell transmission. However, the host immune response to M. tuberculosis also increases HIV-1 transcription. The HIV-1 long terminal repeat (LTR) includes binding sites for several host transcription factors that are activated by innate immune and cytokine signalling pathways. These include the NF-κB, AP1, CCAAT/enhancer-binding protein (C/EBP), CREB/ATF and nuclear factor of activated T cells (NFAT) families of transcription factors 126 . Innate immune activation by M. tuberculosis or mycobacterial products increased HIV-1 transcription and replication in myeloid cell lines through the action of C/EBP, NF-κB and NFAT5 .
Experimental data on the effects of M. tuberculosis infection on HIV-1 transcription in macrophages are inconclusive. In macrophages that were infected with HIV-1, co-infection with BCG caused a dose-dependent suppression of virus production. This was attributed to the C/EBP binding motif in the viral LTR and associated with production of an isoform of C/EBPβ inducible by type 1 interferons, leading to a model in which mycobacterial induction of type 1 interferons may restrict HIV-1 transcription 130 . These data are somewhat inconsistent with the current view of ESX-1-dependent induction of type 1 interferon responses by M. tuberculosis 79 , given that BCG lacks ESX-1 (REF. 131 ). Interestingly, alveolar macrophages from healthy lung tissue express high levels of inhibitory C/EBPβ, but this is strongly downregulated in cells that are isolated from the site of pulmonary TB 130 , suggesting that the pro-inflammatory milieu present in active TB granulomas overcomes type 1 interferon-mediated inhibition of virus transcription. Direct evidence for this hypothesis was shown in HIV-1-infected macrophages where co-infection with M. tuberculosis led to an initial decrease in HIV-1 transcription followed by a substantial increase 121 . The increase in virus transcription was co-incident with sustained pro-inflammatory responses as a result of HIV-1 attenuation of early IL-10 regulatory responses, and complementation of deficient IL-10 responses reversed the increase in viral transcription in M. tuberculosis co-infected macrophages 121 . IL-10 has been reported to inhibit HIV-1 transcription by signal transducer and activator of transcription 3 (STAT3)-dependent induction of inhibitory C/EBPβ and by inhibition of cyclin T1 that is required for HIV-1 Tat-dependent trans activation of viral transcription [132] [133] [134] . Conversely, Nature Reviews | Microbiology 139 , and for maintenance of embryologically derived resident populations [140] [141] [142] . Recent findings show that polyploid giant cells within granulomas arise from macrophages that enter the cell cycle but do not complete cytokinesis 143 . In addition, macrophages that enter the cell cycle but arrest in a G1-like state, downregulate SAMHD1 activity to allow DNA synthesis and consequently become more permissive to HIV-1 by facilitating reverse transcription 30 . Thus, the pro-inflammatory cytokine response to M. tuberculosis (facilitated by HIV-1 attenuation of immune regulation), recruitment and activation of T cells and modu lation of the macrophage cell cycle phenotype act in concert to enhance virus replication and propagation (FIG. 4) . Hence, these co-infecting pathogens successfully cooperate to usurp host defences to their own advantage.
Future perspectives
In resource-poor settings where the highest incidence of HIV-1 and M. tuberculosis co-infection is found, ART has substantially reduced the incidence of co-infection and improved clinical outcomes 144 . In the pre-ART era, the majority of co-infections were observed in people with advanced HIV-1 disease. Assuming that ART programmes continue to grow in these settings, the majority of morbidity and mortality that is associated with HIV-1 and M. tuberculosis co-infection may be caused by the increased risk of TB in patients with early HIV-1 infection before ART initiation; TB-IRIS arising in patients starting ART; and the residual increased risk of active TB in patients on ART. Therefore, ongoing research that focuses on the mechanisms by which the two pathogens interact in these circumstances and identification of possible therapeutic targets is necessary. Specific priorities include being able to stratify the risks of active TB in order to inform optimal use of systematic screening for active TB or strategies for preventive therapy; to identify opportunities for host-directed therapies that treat or reduce the risk of TB-IRIS or population-level interventions to reduce the risk of active TB, such as vitamin D supplementation; and to evaluate the effects of active TB or LTBI on subclinical viral replication and diversification that may promote HIV-1 drug resistance and persistence.
The application of whole-genome sequencing and single-genome amplification 145 will offer greater depths of resolution to explore the effect of M. tuberculosis co-infection on HIV-1 diversity. Likewise, whole-genome sequencing of M. tuberculosis is expected to offer more insight into transmission chains 146 in order to assess the effect of HIV-1 on the spread of M. tuberculosis Nature Reviews | Microbiology 
